We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

Whitepaper

Respiratory Syncytial Virus Antigens and Antibodies

Respiratory syncytial virus (RSV) has a high mortality rate and is the leading cause of lower respiratory tract infections in children and infants worldwide.
Whitepaper

Advanced Reagents for SARS-CoV-2 Neutralizing Antibody Detection

The COVID-19 pandemic has continued to spread worldwide, with an increasing number of global infections and the continual emergence of new variants. Are the existing vaccines still effective against new variants?
Whitepaper

Quality Assurance in IVT RNA Vaccine Development

Quality Assurance in In Vitro Transcribed RNA Vaccine Development Using Agilent Automated Electrophoresis Instruments
Whitepaper

New for Old: The Value of Transitioning from qPCR to ddPCR

Droplet Digital PCR (ddPCR) is a refined form of digital PCR that offers a scalable and practical method for the absolute quantification of nucleic acids. 2021 marks ten years since the advent of ddPCR and in that time it has revolutionized discovery, development and quality control of biopharmaceuticals such as antibody-based biologics, vaccines, and cell and gene therapies.
Whitepaper

Advances in the Stability and Delivery of mRNA Therapeutics

Download this whitepaper to learn more about mRNA therapeutics including how they could treat genetic diseases and cancer, the challenges associated with delivery and dosage as well as how to avoid an unwanted immune response.
Whitepaper

mRNA Vaccine Approvals for COVID-19

In this cell and gene therapy insights expert roundtable, a panel of four experts will answer some central questions surrounding the development of novel biotherapeutics.
Whitepaper

Advancing the Development of Therapeutics Against Infectious Diseases

Novel and emerging infectious diseases can be a serious threat to human health and the global economy, as exhibited by the current SARS-CoV-2 outbreak. To mitigate these threats, it is necessary to initiate comprehensive containment strategies such as
Whitepaper

Investigating Synthetic Immune Recruitment by Proximity Inducing Molecules

Download this whitepaper to learn how Octet® Bio-Layer Interferometry (BLI) assays can accelerate the advancement of lead compounds to in vivo validation studies.
Whitepaper

Gold-Standard RT-PCR Detection of SARS-CoV-2 at Rapid Speed: A Solution for Asymptomatic Screening

Screening tests are intended to identify infected individuals who may be contagious, regardless of whether they are displaying symptoms, so that measures can be taken to prevent those individuals from infecting others.
Whitepaper

What Is Your CO2 Incubator Telling You?

Download this whitepaper to learn more about the three types of incubator monitoring, the level of data and visibility your incubator provides as well as monitoring physiological pH.
Advertisement